ARCHIVES

Early HER2 Positive Patients At Higher Risk of Recurrence

This article is from The Cancer Letter archive.

Vol. 32 No. 1 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

NCI Workshop Not “A Formality,” Baines Responds To Kopans

November 19, 1993

Oncology Societies, Cancer Center, List Reform Principles

August 12, 1994

Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum

January 8, 1993

Low Dose Therapy Improves Survival Of Multiple Myeloma, ECOG Finds; Update At ASCO

May 25, 2007

ACS Study Shows Reduced Mortality For Low T/N Brands

April 18, 1980

Immunoassays For Isoenzymes

April 15, 1983